CORT logo

CORT Stock Overview

Profile

Full Name:

Corcept Therapeutics Incorporated

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

April 14, 2004

Indexes:

Not included

Website:

http://www.corcept.com

Description:

Corcept Therapeutics Incorporated is an American pharmaceutical company headquartered in Menlo Park, California, specializing in the development of drugs for patients with metabolic and oncological diseases, as well as mental disorders. It was founded in 1998. The company has focused on the side effects of excess cortisol (a hormone produced by the adrenal glands), studying new compounds that can alleviate these effects. Since 2012, it has been marketing Korlym (mifepristone) for the treatment of patients suffering from Cushing's syndrome, a condition caused by excessive cortisol activity. The drug is sold exclusively in the United States through sales representatives, specialized pharmacies, and distributors. The drug is manufactured by third-party organizations such as Produits Chimiques Auxiliaires et de Synthes SA.

Key Details

Price

$54.89

Market Cap

$5.79 B(Mid cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$675.04 M(+39.94% YoY)

Annual EPS

$1.23(+30.85% YoY)

PE Ratio

44.27

Annual ROE

23.81%

Annual Debt To Equity

0.00

Beta

-

Events Calendar

Earnings

Next earnings date:

May 1, 2025

Recent quarterly earnings:

Feb 26, 2025

Recent annual earnings:

Feb 26, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Feb 27, 25 Piper Sandler
Overweight
Feb 27, 25 HC Wainwright & Co.
Buy
Feb 11, 25 HC Wainwright & Co.
Buy
Feb 7, 25 HC Wainwright & Co.
Buy
Jan 30, 25 Canaccord Genuity
Buy
Oct 31, 24 HC Wainwright & Co.
Buy
Oct 18, 24 HC Wainwright & Co.
Buy
Sep 30, 24 Truist Securities
Buy
Sep 18, 24 Piper Sandler
Overweight
Jul 31, 24 Canaccord Genuity
Buy

Screeners with CORT included

Growing Shares Outstanding
Mid cap stocks
US stocks
Stocks with high beta
Most recommended stocks
Best performing stocks last 5 years
Stocks below analysts price target
High revenue growth stocks
Healthcare sector
All stocks

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$54.89
CORT price is $54.89

Price All-time High

$74.84
CORT price is currently -26.66% below its historical high of $74.84

Price Analysts Target

$96.50
CORT price is currently -43.12% lower than the consensus analysts' forecast

Price Today Change

-0.97%
CORT price is down -0.97% today

Price YTD Change

+2.6%
CORT price is up +2.6% since January 1st

Price 3-Year Change

+125.7%
CORT price is up +125.7% over the past 3 years

Market cap

Market Cap

$5.79 B
CORT market capitalization is $5.79 billion

Market Cap 3-Year Change

+124.72%
CORT market capitalization is up +124.72% over the past 3 years

Market Cap All-time High

$7.88 B
CORT market capitalization is currently -26.54% below its historical high of $7.88 billion

Market Cap Sector Rank

89.79%
CORT market capitalization is higher than 89.79% of companies in Healthcare sector

Technical

Beta

-
CORT beta value is unknown

200-day SMA

$46.15
CORT price is currently +18.93% above its 200-day simple moving average

14-day RSI

-
CORT 14-day relative strength index value is unknown

30-day Relative Volume

0.82
CORT 30-day relative volume is 0.82

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$675.04 M
CORT annual revenue is $675.04 million

Annual Revenue Analysts Estimate

$905.39 M
CORT annual revenue is currently -25.44% lower than the consensus analysts' forecast

Annual Revenue 1-Year Change

+39.94%
CORT annual revenue is up +39.94% year-on-year

Annual Revenue Sector Rank

76.3%
CORT annual revenue is higher than 76.3% of companies in Healthcare sector

Profit

Annual Gross Profit

$664.16 M
CORT annual gross profit is $664.16 million

Annual Gross Margin

98.39%
CORT annual gross profit margin is 98.39%

Annual Operating Profit

$136.95 M
CORT annual operating income is $136.95 million

Annual Operating Margin

20.29%
CORT annual operating profit margin is 20.29%

Annual Net Income

$141.21 M
CORT annual net profit is $141.21 million

Annual Net Margin

20.92%
CORT annual net profit margin is 20.92%

EPS

Annual EPS

$1.23
CORT annual earnings per share is $1.23

Annual EPS Analysts Estimate

$1.91
CORT annual earnings per share is currently -35.60% lower than the consensus analysts' forecast

Annual EPS 1-Year Change

+30.85%
CORT annual earnings per share is up +30.85% year-on-year

Annual EPS Sector Rank

90.05%
CORT annual earnings per share is higher than 90.05% of companies in Healthcare sector

ROA & ROE

Annual ROA

19.32%
CORT annual return on assets is 19.32%

Annual ROE

23.81%
CORT annual return on equity is 23.81%

EBIT & EBITDA

Annual EBIT

$136.95 M
CORT annual earnings before interest & taxes is $136.95 million

Annual EBITDA

$138.29 M
CORT annual EBITDA is $138.29 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

44.27
CORT price to earnings ratio is 44.27

PE Ratio Sector Rank

75.86%
CORT price to earnings ratio is higher than 75.86% of companies in Healthcare sector

PB Ratio

PB Ratio

8.52
CORT price to book ratio is 8.52

PB Ratio Sector Rank

90.68%
CORT price to book ratio is higher than 90.68% of companies in Healthcare sector

PS Ratio

PS Ratio

8.58
CORT price to sales ratio is 8.58

PS Ratio Sector Rank

76.73%
CORT price to sales ratio is higher than 76.73% of companies in Healthcare sector

Enterprise value

Enterprise Value

$5.67 B
CORT enterprise value is $5.67 billion

Enterprise Value Sector Rank

88.37%
CORT enterprise value is higher than 88.37% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

41.00
CORT EV/EBITDA is 41.00

EV/EBITDA Sector Rank

95.97%
CORT EV/EBITDA is higher than 95.97% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

3.35
CORT annual current ratio is 3.35

Annual Quick Ratio

3.26
CORT annual quick ratio is 3.26

Leverage

Annual Debt To Equity

0.00
CORT annual debt to equity ratio is 0.00

Annual Interest Coverage Ratio

-
CORT annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

5
CORT piotroski f-score is 5

Altman Z-Score

24.31
CORT altman z-score is 24.31

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$840.55 M
CORT annual total assets is $840.55 million

Annual Non Current Assets

$368.95 M
CORT annual long term assets is $368.95 million

Annual Current Assets

$471.60 M
CORT annual total current assets is $471.60 million

Annual Cash & Cash Equivalents

$127.67 M
CORT annual cash & cash equivalents is $127.67 million

Equity

Annual Book Value

$679.59 M
CORT annual book value is $679.59 million

Annual Working Capital

$330.83 M
CORT annual working capital is $330.83 million

Liabilities

Annual Total Liabilities

$160.96 M
CORT annual total liabilities is $160.96 million

Annual Total Long Term Liabilities

$20.19 M
CORT annual total long term liabilities is $20.19 million

Annual Current Liabilities

$140.77 M
CORT annual total current liabilities is $140.77 million

Annual Accounts Payable

$15.38 M
CORT annual accounts payable is $15.38 million

Debt

Annual Total Debt

$6.94 M
CORT annual total debt is $6.94 million

Annual Total Debt 1-Year Change

+4493.38%
CORT annual total debt is up +4493.38% year-on-year

Annual Long Term Debt

$6.11 M
CORT annual long term debt is $6.11 million

Annual Short Term Debt

$829.00 K
CORT annual short term debt is $829.00 thousand

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$538.09 M
CORT annual total expenses is $538.09 million

Annual Operating Expenses

$527.21 M
CORT annual total operating expenses is $527.21 million

Annual Cost Of Goods Sold

$10.88 M
CORT annual cost of goods sold is $10.88 million

Annual SGA

$280.32 M
CORT annual SGA is $280.32 million

Annual D&A

$1.34 M
CORT annual depreciation & amortization is $1.34 million

Annual Interest Expense

-
CORT annual interest expense value is unknown

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

$198.07 M
CORT annual cash flow from operations is $198.07 million

Annual CFO 1-Year Change

+55.91%
CORT annual cash flow from operations is up +55.91% year-on-year

Annual CFI

-$177.60 M
CORT annual cash flow from investing activities is -$177.60 million

Annual CFI 1-Year Change

-295.37%
CORT annual cash flow from investing activities is down -295.37% year-on-year

Annual CFF

-$28.35 M
CORT annual cash flow from financing activities is -$28.35 million

Annual CFF 1-Year Change

+80.94%
CORT annual cash flow from financing activities is up +80.94% year-on-year

Free CashFlow

Annual FCF

$195.90 M
CORT annual free cash flow is $195.90 million

Annual FCF 1-Year Change

+54.37%
CORT annual free cash flow is up +54.37% year-on-year

CAPEX

Annual CAPEX

$2.17 M
CORT annual capital expenditures is $2.17 million

Annual CAPEX 1-Year Change

+1462.59%
CORT annual capital expenditures is up +1462.59% year-on-year

Institutional Ownership

Similar stocks

BBIO logo
BridgeBio Pharma (BBIO)
TGTX logo
TG Therapeutics (TGTX)
AXSM logo
Axsome Therapeutics (AXSM)
MMSI logo
Merit Medical Systems (MMSI)
STVN logo
Stevanato Group SpA (STVN)
GKOS logo
Glaukos (GKOS)
BPMC logo
Blueprint Medicines (BPMC)
Telix Pharmaceuticals Limited (TLX)
OPCH logo
Option Care Health (OPCH)

FAQ

  • What is the ticker symbol for Corcept Therapeutics Incorporated?
  • Does Corcept Therapeutics Incorporated pay dividends?
  • What sector is Corcept Therapeutics Incorporated in?
  • What industry is Corcept Therapeutics Incorporated in?
  • What country is Corcept Therapeutics Incorporated based in?
  • When did Corcept Therapeutics Incorporated go public?
  • Is Corcept Therapeutics Incorporated in the S&P 500?
  • Is Corcept Therapeutics Incorporated in the NASDAQ 100?
  • Is Corcept Therapeutics Incorporated in the Dow Jones?
  • When was Corcept Therapeutics Incorporated's last earnings report?
  • When does Corcept Therapeutics Incorporated report earnings?
  • Should I buy Corcept Therapeutics Incorporated stock now?

What is the ticker symbol for Corcept Therapeutics Incorporated?

The ticker symbol for Corcept Therapeutics Incorporated is NASDAQ:CORT

Does Corcept Therapeutics Incorporated pay dividends?

No, Corcept Therapeutics Incorporated does not pay dividends

What sector is Corcept Therapeutics Incorporated in?

Corcept Therapeutics Incorporated is in the Healthcare sector

What industry is Corcept Therapeutics Incorporated in?

Corcept Therapeutics Incorporated is in the Biotechnology industry

What country is Corcept Therapeutics Incorporated based in?

Corcept Therapeutics Incorporated is headquartered in United States

When did Corcept Therapeutics Incorporated go public?

Corcept Therapeutics Incorporated's initial public offering (IPO) was on April 14, 2004

Is Corcept Therapeutics Incorporated in the S&P 500?

No, Corcept Therapeutics Incorporated is not included in the S&P 500 index

Is Corcept Therapeutics Incorporated in the NASDAQ 100?

No, Corcept Therapeutics Incorporated is not included in the NASDAQ 100 index

Is Corcept Therapeutics Incorporated in the Dow Jones?

No, Corcept Therapeutics Incorporated is not included in the Dow Jones index

When was Corcept Therapeutics Incorporated's last earnings report?

Corcept Therapeutics Incorporated's most recent earnings report was on Feb 26, 2025

When does Corcept Therapeutics Incorporated report earnings?

The next expected earnings date for Corcept Therapeutics Incorporated is May 1, 2025

Should I buy Corcept Therapeutics Incorporated stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions